Companies in Africa and India will make generic versions of the pill that could cost as little as $5 per person per year. But access to the drug and other new products in much of Latin America remains uncertain.
With Hopes High for New H.I.V. Prevention Pill, Merck Takes Steps to Ensure Access
Originally reported by New York Times. Read the full story at the original source.
Related Articles
Burnham urged to lobby EU leaders directly to waive new border controls
EES kiosks at Madrid airport. Spain will be the main destination for the 2.2 million Britons expected to head abroad th...
Bangladesh’s President Resigns Amid Uncertainty Over Ex-Leader’s Plans
President Mohammed Shahabuddin stepped down as speculation swirled over the possible return of his onetime ally Sheikh H...
Trump’s latest tariffs put UK at disadvantage to EU, say experts
While overall levy for UK is unchanged, sectors not covered by Turnberry deal face tougher competitionBusiness live – la...
Gangs taking villages on Brazil-Peru border ‘hostage’, say Indigenous leaders
Delegation sent to Brasília after gunmen from organised crime group enter homes in western Amazon ForestIndigenous leade...